HULIO sol inj 40 mg/0.8ml stylo pré 2 x 0.8 ml

7680676110024 CH-67611 L04AB04 07.15.0.

Reimbursement limitations:

HULIO4

Substitution préparation de référence/biosimilaire
Le traitement par HULIO exige une garantie préalable de prise en …

HULIO sol inj 40 mg/0.8ml stylo pré 2 x 0.8 ml
HULIO sol inj 40 mg/0.8ml stylo pré 2 x 0.8 ml
HULIO sol inj 40 mg/0.8ml stylo pré 2 x 0.8 ml
1 / 3
google

Details

Product number
6761101
CPT
-
Packaging group
2
Unit
Injektor(en), vorgefüllt/Pen
Composition
adalimumabum 40 mg, natrii hydrogenoglutamas anhydricus, sorbitolum 38.2 mg, methioninum, polysorbatum 80, acidum hydrochloridum, aqua ad iniectabile q.s. ad solutionem pro 0.8 ml corresp. natrium 184 µg.

Articles (1)

Hulio 40 mg/0.8 ml, Injektionslösung im Fertigpen
Injektionslösung im Fertigpen
2
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
27/09/2025
Patient information leaflet
Français
27/09/2025
Patient information leaflet
Italien
27/09/2025
Professional SmPC
Allemand
27/09/2025
Professional SmPC
Français
27/09/2025
Professional SmPC
Italien
27/09/2025

Detailed composition

Substance Quantity Type Category
(N/A)
40.0 MG Substance Wirkstoff (Principe actif)
(N/A)
- Substance AIMDK
(N/A)
38.2 MG Substance HBESI
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
184.0 UG Substance HBESI

Reimbursement information

Public price
CHF 823.50
Specialties list
Yes
Generic
No

Reimbursement limitation

SL addition date: 01/08/2020

Authorization holder

Medius AG

4132 Muttenz

Authorization information

Swissmedic authorization number
67611
Drug name
Hulio, Injektionslösung im Fertigpen
Galenic form
INLFP
ATC Code
L04AB04
Authorization status
Z
Dispensation category
B
First authorization
13/05/2020
Authorization expiration date
31/12/9999
IT number
07.15.0.
Domain
Human medicine
Field of application
Rheumatoide Arthritis, polyartikuläre juvenile Arthritis ab 30 kg Körpergewicht, Psoriasis-Arthritis, ankylosierende Spondylitis (Morbus Bechterew), Morbus Crohn bei Erwachsenen, Colitis Ulcerosa, Psoriasis bei Erwachsenen, Kindern und Jugendlichen ab 30 kg Körpergewicht, Hidradenitis suppurativa, Uveitis

Packaging details

Description (FR)
HULIO sol inj 40 mg/0.8ml stylo pré 2 x 0.8 ml
Description (DE)
HULIO Inj Lös 40 mg/0.8ml Fertpen 2 x 0.8 ml
Market launch
13/05/2020
Narcotic (BTM)
No

Other packaging sizes

HULIO sol inj 40 mg/0.8ml stylo pré 0.8 ml
1 INJ
View